• Nebula Genomics Signs Agreement for Pilot Project with EMD Serono firstwordpharma
    June 12, 2019
    Nebula Genomics, which operates a technology platform containing genome-sequencing data, has signed an agreement with EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the U.S. and Canada, for EMD Serono to access genomic dat
PharmaSources Customer Service